Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $1.75 Million - $2.48 Million
5,799 New
5,799 $1.82 Million
Q3 2021

Nov 15, 2021

SELL
$396.76 - $455.92 $833,196 - $957,432
-2,100 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$372.36 - $412.07 $4.92 Million - $5.44 Million
-13,200 Reduced 86.27%
2,100 $832,000
Q1 2021

May 12, 2021

BUY
$357.26 - $392.57 $2.95 Million - $3.24 Million
8,266 Added 117.51%
15,300 $5.88 Million
Q4 2020

Feb 11, 2021

BUY
$319.05 - $363.32 $1.86 Million - $2.12 Million
5,834 Added 486.17%
7,034 $2.56 Million
Q3 2020

Nov 16, 2020

BUY
$280.08 - $347.78 $336,096 - $417,335
1,200 New
1,200 $405,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.